Scienture (NASDAQ:SCNX) Shares Down 1.7% – Time to Sell?

Scienture Holdings, Inc. (NASDAQ:SCNX) traded down 1.7% during mid-day trading on Friday . The company traded as low as $1.39 and last traded at $1.44. 173,670 shares were traded during mid-day trading, a decline of 82% from the average session volume of 944,217 shares. The stock had previously closed at $1.46.

Scienture Stock Performance

The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.01. The business’s fifty day simple moving average is $0.99 and its 200-day simple moving average is $2.39.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Monday, May 12th. The company reported ($0.33) earnings per share for the quarter. The firm had revenue of $0.01 million for the quarter. Scienture had a negative net margin of 10,364.22% and a negative return on equity of 22.57%.

Hedge Funds Weigh In On Scienture

A hedge fund recently bought a new stake in Scienture stock. Geode Capital Management LLC acquired a new position in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 20,565 shares of the company’s stock, valued at approximately $124,000. Geode Capital Management LLC owned approximately 0.24% of Scienture at the end of the most recent reporting period. Institutional investors and hedge funds own 5.68% of the company’s stock.

Scienture Company Profile

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.